Compounded semaglutide associated with at least 10 deaths, Novo Nordisk …
Nov 6, 2024 · Novo Nordisk said the data on 10 deaths and more than 100 hospitalizations came from the US Food and Drug Administration’s adverse event reporting database for semaglutide; the FDA warns that ...
Novo Nordisk CEO Warns of Deaths Linked to Compounded …
THURSDAY, Nov. 7, 2024 (HealthDay News) -- The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in...
Ozempic, Wegovy maker Novo Nordisk faces hearing over high …
Sep 24, 2024 · Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO testified on Capitol Hill Tuesday.
Novo Nordisk asks FDA to ban compounded Ozempic, Wegovy …
Oct 23, 2024 · Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its popular weight loss injection Wegovy...
Ozempic linked to lower Alzheimer's risk in people with Type ... - NBC News
Oct 24, 2024 · Novo Nordisk, which makes Ozempic and Wegovy, is running two phase 3 clinical trials comparing semaglutide to a placebo in more than 3,000 patients with mild cognitive impairment or...
Novo Nordisk sues two pharmacies for allegedly offering ... - NBC News
Nov 30, 2023 · Two compounding pharmacies in Florida are allegedly offering contaminated copycat versions of semaglutide, the drug found in Ozempic and Wegovy, Novo Nordisk said Thursday. The claims are...
News details - Novo Nordisk
Jun 24, 2024 · Based on data from the FLOW clinical trial, Novo Nordisk submitted a label extension application for Ozempic ®, which has been accepted for review by the U.S. Food & Drug Administration (FDA). A decision is anticipated in January 2025.
News Details - Novo Nordisk
Mar 5, 2024 · Novo Nordisk expects to file for regulatory approvals of a label expansion for Ozempic ® in the US and EU in 2024. The detailed results from FLOW will be presented at a scientific conference in 2024.
The Maker of Ozempic Is Trying to Block Compounded Versions …
Oct 23, 2024 · Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. ... Ozempic and Wegovy can cost around $1,000 a month without ...
Ozempic Maker Novo Nordisk Plans Bond Sale to Fund Expansion
May 13, 2024 · Novo Nordisk A/S plans to sell bonds for the first time in more than two years to help finance its large program to expand production of its blockbuster treatments.